Researchers have developed an algorithm for differentiating between healthy women and those with ovarian cancer, as well as differentiating BRCA1 mutated-disease from wild-type disease.READ MORE
From January 18-20, the American Society of Clinical Oncology will be hosting its Annual Gastrointestinal Cancers Symposium in San Francisco, California. The meeting will highlight some of the largest updates in multidisciplinary care for gastrointestinal cancers, both in the local practice and global settings. READ MORE
To gain a better understanding of the newly available options for patients with this hematologic malignancy, Journal of Clinical Pathways spoke with Natalie S Callander, MD, professor of hematology/oncology at University of Wisconsin School of Medicine and Public Health (Madison, WI). READ MORE
The European Medicines Agency approved its first biosimilar product in 2006; the United States biosimilar market remains in its infancy. The United States must look to the European Union as biosimilar adoption continues to grow. READ MORE